Company Overview and News

0
Visaka Industries Limited - Shareholders meeting

2018-06-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509055 VISAKAIND

0
Visaka Industries Limited - Updates

2018-06-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509055 VISAKAIND

0
Visaka Industries Limited - Updates

2018-05-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509055 VISAKAIND

0
Visaka Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509055 VISAKAIND

0
Visaka Industries Limited - Dividend

2018-05-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509055 VISAKAIND

0
Visaka Industries Limited - AGM/Book Closure

2018-05-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509055 VISAKAIND

0
Visaka Industries Limited - Financial Result Updates

2018-05-07 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509055 VISAKAIND

0
Visaka Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509055 VISAKAIND

39
Closing Bell: Sensex ends 200 pts higher, Nifty closes above 10,600; PSU banks fall

2018-04-26 moneycontrol
3:30 pm Market at Close: Shares have ended the day on a strong note, with the Sensex rising over 200 points, while the Nifty is above 10,600-mark.The market breadth is negative as 1102 shares advanced against a decline of 1507 shares, while 177 shares were unchanged.
RMGALLOY 500408 500325 VISAKAIND 532832 534816 500134 500570 RLNIY UNIPLY AXB RELCAPITAL YYBKY STS AXBA ROHLTD 500180 534809 TCS PCJEWELLER IBREALEST RALLIS BHRYY 533150 RELIANCE NFL BHRQY TTNQY 532699 532215 SHAHALLOYS SPMWY EQMNY 532540 AXISBANK RIGD SUPREMEIND 500355 INFRATEL HDFCBANK BHARTIARTL TATAMOTORS 503100 523630 500111 YESBANK 517354 HVLQY PHOENIXLTD IBN ESSAROIL 532648 513436 532646 TAKE AXBKY 532454 ICICIBANK GODREJPROP 532890 HDB 532174 500365 HAVELLS TATAELXSI 509055 509930 TTM

14
Market Live: Nifty eyes 10,600 ahead of expiry; Realty index outshines after Mumbai Development Plan

2018-04-26 moneycontrol
10:45 am Buzzing: Shares of Mahindra & Mahindra Financial Services touched a 52-week high of Rs 532, rising 4.8 percent on the back of robust Q4 numbers.
500408 RALLIS 533150 VISAKAIND 532832 532699 532215 SHAHALLOYS EQMNY AXISBANK 500355 503100 500111 YESBANK UNIPLY AXB PHOENIXLTD RELCAPITAL 532648 YYBKY 513436 532646 AXBKY AXBA GODREJPROP ROHLTD 509055 TATAELXSI IBREALEST

14
Market Live: Nifty inching towards 10,600 ahead of expiry; Wipro falls 4% post Q4 nos

2018-04-26 moneycontrol
9:38 am Market Update: The market traded mildly higher amid consolidation ahead of expiry of April derivative contracts today.
YESBANK 500408 RALLIS UNIPLY RELCAPITAL AXB 532648 YYBKY VISAKAIND 532646 532699 532215 AXBKY AXBA EQMNY ROHLTD AXISBANK 500355 509055 TATAELXSI 500111

0
Visaka Industries Limited - Investor Presentation

2018-04-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
509055 VISAKAIND

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...